{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:03:48Z","timestamp":1777518228939,"version":"3.51.4"},"reference-count":171,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#am"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["R01 AI134952"],"award-info":[{"award-number":["R01 AI134952"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["R01 DC016645"],"award-info":[{"award-number":["R01 DC016645"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int Forum Allergy Rhinol"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic rhinosinusitis with nasal polyps (CRSwNP) represents a challenging disease entity with significant rates of recurrence following appropriate medical and surgical therapy. Recent approval of targeted biologics in CRSwNP compels deeper understanding of underlying disease pathophysiology. Both of the approved biologics for CRSwNP modulate the type 2 inflammatory pathway, and the majority of drugs in the clinical trials pathway are similarly targeted. However, there remain multiple other pathogenic mechanisms relevant to CRSwNP for which targeted therapeutics already exist in other inflammatory diseases that have not been studied directly. In this article we summarize pathogenic mechanisms of interest in CRSwNP and discuss the results of ongoing clinical studies of targeted therapeutics in CRSwNP and other related human inflammatory diseases.<\/jats:p>","DOI":"10.1002\/alr.22787","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T23:25:49Z","timestamp":1614813949000},"page":"1220-1234","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Targetable pathogenic mechanisms in nasal polyposis"],"prefix":"10.1002","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9013-646X","authenticated-orcid":false,"given":"Alexander L.","family":"Schneider","sequence":"first","affiliation":[{"name":"Department of Otolaryngology, Head and Neck Surgery  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Schleimer","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Head and Neck Surgery  Chicago Illinois USA"},{"name":"Division of Allergy\u2010Immunology, Department of Medicine Northwestern University Feinberg School of Medicine  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9210-5050","authenticated-orcid":false,"given":"Bruce K.","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Head and Neck Surgery  Chicago Illinois USA"},{"name":"Division of Allergy\u2010Immunology, Department of Medicine Northwestern University Feinberg School of Medicine  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1527904"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.06.063"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0000000000000594"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2010.04.003"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.01.031"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2009.07.001"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-019-0303-6"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0014.2449"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00235"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00146-10"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.5.2832"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13051"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.4089"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.032"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22633"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61452-X"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1324"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.05.004"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.09.009"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.05.041"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.2017.7.3.121"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2018.10.014"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1945892418787132"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.05.009"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2017.08.009"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.161"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2104"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12472"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.08.001"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.04.101"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.04.019"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.11.017"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-016-0650-5"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4624"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm734"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-052016-100401"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1092"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212587"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1159\/000237239"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.02.023"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1067\/mhn.2002.121022"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2009.01995.x"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.10.012"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1988.tb02840.x"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.47.2.76"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00064204"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1"},{"issue":"4","key":"e_1_2_5_50_1","first-page":"183","article-title":"Staging in rhinosinusitus","volume":"31","author":"Lund VJ","year":"1993","journal-title":"Rhinology"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-016-0617-6"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21964"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1298443"},{"issue":"11","key":"e_1_2_5_54_1","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.4049\/jimmunol.145.11.3796","article-title":"IL\u20104 directs the development of Th2\u2010like helper effectors","volume":"145","author":"Swain SL","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.147.1.8"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.1.108"},{"key":"e_1_2_5_57_1","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.2000.0814"},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.03.048"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.07.012"},{"key":"e_1_2_5_60_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5397.2258"},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314768"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.19330"},{"key":"e_1_2_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.03.023"},{"key":"e_1_2_5_64_1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.4.6.743"},{"key":"e_1_2_5_65_1","doi-asserted-by":"publisher","DOI":"10.1159\/000447692"},{"key":"e_1_2_5_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2013.01.024"},{"key":"e_1_2_5_67_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106469"},{"key":"e_1_2_5_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13731"},{"key":"e_1_2_5_69_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S211032"},{"key":"e_1_2_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2008.04.001"},{"issue":"2","key":"e_1_2_5_71_1","first-page":"125","article-title":"240563, anti\u2010IL\u20105 monoclonal antibody \u2010 GlaxoSmithKline, anti\u2010interleukin\u20105 monoclonal antibody \u2010 GlaxoSmithKline, SB 240563","volume":"9","year":"2008","journal-title":"Drugs R D"},{"key":"e_1_2_5_72_1","unstructured":"FDA.gov.Mepolizumab. [Webpage].2017[updated 12\/2017. Available from:https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/761122s000lbl.pdf."},{"key":"e_1_2_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.07.056"},{"key":"e_1_2_5_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.05.044"},{"key":"e_1_2_5_75_1","unstructured":"Nucala (mepolizumab) is the first anti\u2010IL5 biologic to report positive phase 3 results in patients with nasal polyps [press release].2020."},{"key":"e_1_2_5_76_1","first-page":"7","article-title":"Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma","volume":"7","author":"Walsh GM","year":"2013","journal-title":"Biologics"},{"key":"e_1_2_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.12.1871"},{"key":"e_1_2_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.05.031"},{"issue":"2","key":"e_1_2_5_79_1","first-page":"589\u2010596 e3","article-title":"Effects of reslizumab on asthma outcomes in a subgroup of eosinophilic asthma patients with self\u2010reported chronic rhinosinusitis with nasal polyps","volume":"7","author":"Weinstein SF","year":"2019","journal-title":"J. Allergy Clin. Immunol"},{"key":"e_1_2_5_80_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.642359"},{"key":"e_1_2_5_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03854.x"},{"key":"e_1_2_5_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.04.004"},{"key":"e_1_2_5_83_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00936-2018"},{"key":"e_1_2_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.12.038"},{"key":"e_1_2_5_85_1","unstructured":"Fasenra met both co\u2010primary endpoints of reduced nasal polyp size and blockage in the OSTRO Phase III trial for patients with chronic rhinosinusitis with nasal polyps [press release].2020."},{"key":"e_1_2_5_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/164_2016_65"},{"key":"e_1_2_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.08.054"},{"key":"e_1_2_5_88_1","unstructured":"Novartis.ca. Product monograph: Xolair: Novartis.ca; 2017[Available from:https:\/\/www.novartis.ca\/sites\/www.novartis.ca\/files\/xolair_scrip_e.pdf."},{"issue":"3","key":"e_1_2_5_89_1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.158.3.1438","article-title":"Down\u2010regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti\u2010IgE antibody","volume":"158","author":"MacGlashan DW","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_5_90_1","doi-asserted-by":"publisher","DOI":"10.1186\/2045-7022-3-29"},{"key":"e_1_2_5_91_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin09.144"},{"key":"e_1_2_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.047"},{"key":"e_1_2_5_93_1","unstructured":"FDA Accepts Supplemental Biologics License Application for Xolair (Omalizumab) for the Treatment of Nasal Polyps [press release].2019."},{"key":"e_1_2_5_94_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201212-2227OC"},{"key":"e_1_2_5_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.07.010"},{"key":"e_1_2_5_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2014.12.006"},{"key":"e_1_2_5_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13552"},{"key":"e_1_2_5_98_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704064"},{"key":"e_1_2_5_99_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax2945"},{"key":"e_1_2_5_100_1","unstructured":"AnaptysBio Reports Top\u2010Line Data from Interim Analysis of ECLIPSE Phase 2 Clinical Trial of Etokimab in Chronic Rhinosinusitis with Nasal Polyps [press release].2020."},{"key":"e_1_2_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30412-4"},{"key":"e_1_2_5_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13974"},{"key":"e_1_2_5_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.10.056"},{"key":"e_1_2_5_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-018-0064-x"},{"key":"e_1_2_5_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature23469"},{"key":"e_1_2_5_106_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3058"},{"key":"e_1_2_5_107_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126219"},{"key":"e_1_2_5_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.10.004"},{"key":"e_1_2_5_109_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-4112"},{"key":"e_1_2_5_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.03.024"},{"key":"e_1_2_5_111_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000234"},{"key":"e_1_2_5_112_1","unstructured":"Inc A. Study to Evaluate Multiple Doses in Patients With Nasal Polyposis 2016[Available from:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02734849."},{"key":"e_1_2_5_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12616"},{"key":"e_1_2_5_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13642"},{"key":"e_1_2_5_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.006"},{"key":"e_1_2_5_116_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00082"},{"key":"e_1_2_5_117_1","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2017.31.4423"},{"key":"e_1_2_5_118_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411776"},{"key":"e_1_2_5_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/380627a0"},{"key":"e_1_2_5_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/380630a0"},{"key":"e_1_2_5_121_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0713433"},{"key":"e_1_2_5_122_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142212"},{"key":"e_1_2_5_123_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1999.00405.x"},{"key":"e_1_2_5_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.01.018"},{"key":"e_1_2_5_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.08.042"},{"key":"e_1_2_5_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep12010"},{"key":"e_1_2_5_127_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.5.1898"},{"key":"e_1_2_5_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(04)03294-5"},{"issue":"59","key":"e_1_2_5_129_1","first-page":"OA3256","article-title":"Discovery of PRS\u2010060, an inhalable CD123\/IL4Ra\/TH2 blocking anti\u2010asthmatic anticalin protein re\u2010engineered from endogenous lipocalin\u20101","volume":"46","author":"Anderson GP","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"62","key":"e_1_2_5_130_1","first-page":"PA1047","article-title":"The Discovery and Development of AZD1402\/PRS\u2010060, an Inhaled, Potent and Selective Antagonist of the IL\u20104 Receptor Alpha","volume":"52","author":"Matschiner G","year":"2018","journal-title":"Eur. Respir. J"},{"issue":"62","key":"e_1_2_5_131_1","first-page":"PA5248","article-title":"AZD1402\/PRS\u2010060, an inhaled Anticalin\u00ae IL\u20104Ra antagonist, potently inhibits IL\u20104 induced functional effects in human whole blood, which can be employed translationally in clinical studies","volume":"52","author":"Pardali K","year":"2018","journal-title":"Eur. Respir. J"},{"issue":"63","key":"e_1_2_5_132_1","first-page":"OA5336","article-title":"Phase 1 evaluation of the inhaled IL\u20104Ra antagonist, AZD1402\/PRS\u2010060, a potent and selective blocker of IL\u20104Ra","volume":"54","author":"Bruns I","year":"2019","journal-title":"Eur. Respir. J"},{"key":"e_1_2_5_133_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201212-2318OC"},{"key":"e_1_2_5_134_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40413-018-0208-1"},{"key":"e_1_2_5_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30048-0"},{"key":"e_1_2_5_136_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969050-00007"},{"key":"e_1_2_5_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30363-4"},{"key":"e_1_2_5_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12809"},{"key":"e_1_2_5_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-002-0500-z"},{"key":"e_1_2_5_140_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2016-0325OC"},{"key":"e_1_2_5_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.04.010"},{"key":"e_1_2_5_142_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0449-8"},{"key":"e_1_2_5_143_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903476"},{"key":"e_1_2_5_144_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203318"},{"key":"e_1_2_5_145_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700461"},{"key":"e_1_2_5_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2008.06.030"},{"key":"e_1_2_5_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.01.043"},{"key":"e_1_2_5_148_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4312"},{"key":"e_1_2_5_149_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000057849.53689.65"},{"key":"e_1_2_5_150_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200419569"},{"key":"e_1_2_5_151_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201207-1292OC"},{"key":"e_1_2_5_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.02.003"},{"key":"e_1_2_5_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2017.03.007"},{"key":"e_1_2_5_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.03.002"},{"key":"e_1_2_5_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.10.072"},{"key":"e_1_2_5_156_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14874"},{"key":"e_1_2_5_157_1","doi-asserted-by":"publisher","DOI":"10.1159\/000355949"},{"key":"e_1_2_5_158_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710127105"},{"key":"e_1_2_5_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.12.143"},{"key":"e_1_2_5_160_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0314-6"},{"key":"e_1_2_5_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.11.031"},{"key":"e_1_2_5_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.053"},{"key":"e_1_2_5_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.01.033"},{"key":"e_1_2_5_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.02.007"},{"key":"e_1_2_5_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.04.010"},{"key":"e_1_2_5_166_1","unstructured":"How Much Should I Expect to Pay for Dupixent? : Sanofi; 2020[Available from:https:\/\/www.dupixent.com\/dupixent-pricing."},{"key":"e_1_2_5_167_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21556"},{"key":"e_1_2_5_168_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13875"},{"key":"e_1_2_5_169_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28648"},{"key":"e_1_2_5_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.07.017"},{"key":"e_1_2_5_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.03.006"},{"key":"e_1_2_5_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.02.036"}],"container-title":["International Forum of Allergy &amp; Rhinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alr.22787","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/alr.22787","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/am-pdf\/10.1002\/alr.22787","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alr.22787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T15:54:56Z","timestamp":1693324496000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/alr.22787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":171,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1002\/alr.22787"],"URL":"https:\/\/doi.org\/10.1002\/alr.22787","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739676545.793583769","asserted-by":"object"}]},"ISSN":["2042-6976","2042-6984"],"issn-type":[{"value":"2042-6976","type":"print"},{"value":"2042-6984","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"2020-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}